These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9893756)

  • 1. Aspirin: benefit and risk in thromboprophylaxis.
    Dickinson JP; Prentice CR
    QJM; 1998 Aug; 91(8):523-38. PubMed ID: 9893756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does aspirin reduce recurrence after completing anticoagulant treatment for an idiopathic thromboembolic event?
    Valenzuela A; Aizman A
    Medwave; 2015 Apr; 15(3):e6118. PubMed ID: 25918851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
    Mutter J; Grandy R; Hulkower S; Stigleman S
    J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which prophylactic aspirin?
    Drug Ther Bull; 1997 Jan; 35(1):7-8. PubMed ID: 9282411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
    Lip GY; Lowe GD
    Br J Clin Pharmacol; 1996 May; 41(5):369-79. PubMed ID: 8735677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.
    Dentali F; Douketis JD; Lim W; Crowther M
    Arch Intern Med; 2007 Jan; 167(2):117-24. PubMed ID: 17242311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical considerations in relation to aspirin prophylaxis.
    Morgan G
    Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEP trial. Pulmonary Embolism Prevention.
    Cohen A; Quinlan D
    Lancet; 2000 Jul; 356(9225):247; author reply 250-1. PubMed ID: 10963215
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleeding risk with aspirin must be balanced against benefit.
    Harv Heart Lett; 2012 Aug; 22(12):8. PubMed ID: 23025025
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
    Palumbo A; Cavo M; Bringhen S; Zamagni E; Romano A; Patriarca F; Rossi D; Gentilini F; Crippa C; Galli M; Nozzoli C; Ria R; Marasca R; Montefusco V; Baldini L; Elice F; Callea V; Pulini S; Carella AM; Zambello R; Benevolo G; Magarotto V; Tacchetti P; Pescosta N; Cellini C; Polloni C; Evangelista A; Caravita T; Morabito F; Offidani M; Tosi P; Boccadoro M
    J Clin Oncol; 2011 Mar; 29(8):986-93. PubMed ID: 21282540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Bretagne JF
    Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
    Serebruany VL; Steinhubl SR; Berger PB; Malinin AI; Baggish JS; Bhatt DL; Topol EJ
    Am J Cardiol; 2005 May; 95(10):1218-22. PubMed ID: 15877994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Account should also have been taken of the harm versus benefit of aspirin use.
    Jolobe OM
    Int J Cardiol; 2015; 187():557-8. PubMed ID: 25863302
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
    Johansen M
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2802-4. PubMed ID: 17086221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tighter aspirin control urged for patients with diabetes. Taking aspirin increases bleeding risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.
    Heart Advis; 2010 Aug; 13(8):6. PubMed ID: 22792576
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin, myocardial infarction, and gastrointestinal bleeding.
    Meade TW
    Lancet; 1999 Feb; 353(9153):676. PubMed ID: 10030366
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patient.
    Loke YK; Bell A; Derry S
    Br J Clin Pharmacol; 2003 Mar; 55(3):282-7. PubMed ID: 12630979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
    Wu IC; Hsieh HM; Yu FJ; Wu MC; Wu TS; Wu MT
    Eur J Clin Invest; 2016 Feb; 46(2):130-40. PubMed ID: 26640116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should patients stop taking aspirin for primary prevention?
    Depta JP; Bhatt DL
    Cleve Clin J Med; 2015 Feb; 82(2):91-6. PubMed ID: 25897597
    [No Abstract]   [Full Text] [Related]  

  • 20. Is low-dose aspirin safe for you? If you take daily aspirin, make sure you know why and understand the small but real bleeding risk.
    Harv Mens Health Watch; 2012 Oct; 17(3):3. PubMed ID: 23175863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.